课题基金 / 基金详情

Phase I trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery

Phase I trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery
恩多昔芬凝胶与安慰剂凝胶在接受乳房手术的女性中进行的 I 期试验
批准号：
9921257
负责人：
Seema Khan
金额：
$12.87万
依托单位：
NORTHWESTERN UNIVERSITY AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
项目状态：
已结题
起止时间：
2017-09-15 至 2020-09-14
来源：
https://reporter.nih.gov/project-details/9921257
关键词：
AddressBreastClinical TrialsCommon Terminology Criteria for Adverse EventsDermalDoseGelPlacebosSafetyWomanbasebreast surgerycohortphase I trial

项目摘要

项目成果

Seema Khan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed clinical trial will address whether daily application of endoxifene gel in escalating dose cohorts is tolerable and safe compared to placebo gel.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OT::IGF::OT A phase I single-arm, multicenter pilot study aimed at validating y-OHPdG as a biomarker and testing the effects of Polyphenon E on its levels in patients with cirrhosis
A phase I single-arm, multicenter pilot study aimed at validating y-OHPdG as a biomarker and testing the effects of Polyphenon E on its levels in patients with cirrhosis
OT::IGF::OT A phase I single-arm, multicenter pilot study aimed at validating y-OHPdG as a biomarker and testing the effects of Polyphenon E on its levels in patients with cirrhosis
Phase I trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery
海外基金